どのようにして企業は、低コストでありながら差別化された戦略を開発するのか？イスラエルのジェネリック医薬品メーカー世界最大手であるテバが、過去20年間に大きな変化を遂げてきたジェネリック医薬品業界において、どのように世界的トップの地位を達成したかを検証する。 How do companies develop a strategy that is both low-cost and differentiated without becoming squeezed in the middle? Describes how Teva, Israel's first and largest multinational, achieved its globally dominant position in generic pharmaceuticals, an industry that has undergone significant change over the last 20 years. Examines its strategies to defend itself against both low-cost competitors from India and other emerging markets as well as Big Pharma companies, which are adopting increasingly aggressive tactics in genetics. This case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details.

【書誌情報】

ページ数：27ページ

サイズ：A4

商品番号：HBSP-719J11

発行日：2006/9/18

登録日：2019/9/30